<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://my.spacstar.com/de/spac-ipo-news/attovia-therapeutics-q2-2026-ergebnisse-und-ipo-update/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T21:47:48Z</news:publication_date>
      <news:title>Attovia Therapeutics: Q2 2026 Ergebnisse und IPO-Update</news:title>
      <news:keywords>Attovia Therapeutics, Q2 2026, Quartalsergebnis, Biotech IPO, ATTO-1310</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/de/spac-ipo-news/inflection-point-acquisition-corp-viii-schliesst-ipo-ab/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T20:47:28Z</news:publication_date>
      <news:title>Inflection Point Acquisition Corp. VIII schließt IPO ab</news:title>
      <news:keywords>IPO, SPAC, IPHXU, Inflection Point Acquisition, Börsengang</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/de/spac-ipo-news/netskope-q2-2027-starkes-wachstum-bei-arr-und-umsatz/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T20:27:20Z</news:publication_date>
      <news:title>Netskope Q2 2027: Starkes Wachstum bei ARR und Umsatz</news:title>
      <news:keywords>Netskope, Quartalszahlen, ARR, Umsatz, Cloud-Sicherheit</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/de/spac-ipo-news/scribe-therapeutics-q2-ergebnisse-2026-und-boersengang/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T20:16:44Z</news:publication_date>
      <news:title>Scribe Therapeutics: Q2-Ergebnisse 2026 und Börsengang</news:title>
      <news:keywords>Scribe Therapeutics, SCTX, Quartalsergebnisse, IPO, Biotechnologie</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/de/spac-ipo-news/advasa-integriert-usdc-zahlungsfunktion-in-advasa-visa-card/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T13:19:35Z</news:publication_date>
      <news:title>Advasa integriert USDC-Zahlungsfunktion in ADVASA Visa Card</news:title>
      <news:keywords>USDC, Visa Card, Fintech, Kryptozahlungen, Advasa</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/de/spac-ipo-news/first-breach-erweitert-munitionsproduktion-auf-20-mio/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T21:12:54Z</news:publication_date>
      <news:title>First Breach erweitert Munitionsproduktion auf 20 Mio.</news:title>
      <news:keywords>First Breach, Munition, Produktion, Kapazität, Verteidigung</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/de/spac-ipo-news/jones-ventures-intl-getrennter-handel-von-aktien/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T20:25:34Z</news:publication_date>
      <news:title>Jones Ventures INTL: Getrennter Handel von Aktien</news:title>
      <news:keywords>JONE, JONEU, JONER, SPAC, IPO</news:keywords>
    </news:news>
  </url>
</urlset>
